Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

Tokai Pharmaceuticals (TKAI) Jumps: Stock Moves Up 6.1%

Tokai Pharmaceuticals, Inc. TKAI was a big mover last session, as the company saw its shares rise over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $5.12 to $7.75 in the past one-month time frame.

The company has seen one positive and one negative estimate revision in the past 30 days. Meanwhile, the Zacks Consensus Estimate moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.

Tokai Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked med-drugs stock is Calithera Biosciences, Inc. CALA with a Zacks Rank #1 (Strong Buy).

Is TKAI going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CALITHERA BIOSC (CALA): Free Stock Analysis Report
 
TOKAI PHARMACT (TKAI): Free Stock Analysis Report
 
To read this article on Zacks.com click here.